Company / Gross Profit
Solventum Gross Profit History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$4.5B
FY2025
5-year range
$4.5B / $4.7B
FY2022-FY2025
Trend
-3.1%
vs FY2024
Sector context
#10 of 100
Health Care
What the data says
Among 100 Health Care companies, Solventum is in the top 10% for gross profit. Gross Profit has declined for 3 consecutive years, from $4.7B in FY2022 to $4.5B in FY2025.
Based on SEC 10-K filings.
$4.5B in FY2025 with a 3-year CAGR of -1.8%. Top quartile in the Health Care sector.
Declined from $4.7B to $4.5B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -1.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 100This company $4.5B Sector average $1.8B
▼
+144.9% above sector average
Key checks
Key Insights
- Solventum's gross profit has declined for 3 consecutive years.
- 3-year CAGR of -1.8%, indicating a declining trend.
- In FY2025, gross profit decreased 3.1% year-over-year.
- Ranks #10 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 30.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.5B | -3.1% |
| FY2024 | $4.6B | -2.1% |
| FY2023 | $4.7B | -0.0% |
| FY2022 | $4.7B | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026